Ignite Creation Date:
2025-12-24 @ 3:38 PM
Ignite Modification Date:
2026-01-09 @ 2:01 AM
Study NCT ID:
NCT04103892
Status:
COMPLETED
Last Update Posted:
2025-10-14
First Post:
2019-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study
Sponsor:
Clexio Biosciences Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-05
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-09
First Submit QC Date:
None
Study First Post Date:
2019-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-09-04
Results First Submit QC Date:
None
Results First Post Date:
2025-09-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-09-14
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-09-28
Last Update Post Date:
2025-10-14
Last Update Post Date Type:
ESTIMATED